Phenotyping by persistent inflammation in systemic sclerosisassociated interstitial lung disease: a EUSTAR database analysis

Rituximab versus intravenous cyclophosphamide in patients with connective tissue disease-associated interstitial lung disease in the UK (RECITAL): a double-blind, double-dummy, randomised, controlled, phase 2b trial

(2022) Toby M Maher et al.   Lancet Respiratory Medicine

Safety and efficacy of rituximab in systemic sclerosis (DESIRES): a double-blind, investigator-initiated, randomised, placebo-controlled trial

(2021) Satoshi Ebata et al.   Lancet Rheumatology

NT-proBNP, hs-cTnT, and CRP predict the risk of cardiopulmonary outcomes in systemic sclerosis: Findings from the Canadian Scleroderma Research Group

(2021) Mayank Jha et al.   Journal of Scleroderma and Related Disorders

Progressive interstitial lung disease in patients with systemic sclerosis-associated interstitial lung disease in the EUSTAR database

(2020) Anna-Maria Hoffmann-Vold et al.   ANNALS OF THE RHEUMATIC DISEASES

Tocilizumab in systemic sclerosis: a randomised, double-blind, placebo-controlled, phase 3 trial

(2020) Dinesh Khanna et al.   Lancet Respiratory Medicine

Nintedanib in Progressive Fibrosing Interstitial Lung Diseases

(2019) Kevin R. Flaherty et al.   NEW ENGLAND JOURNAL OF MEDICINE

High acute phase protein levels correlate with pulmonary and skin involvement in patients with diffuse systemic sclerosis

(2018) Anna Lis-Święty et al.   JOURNAL OF INTERNATIONAL MEDICAL RESEARCH

Short-term progression of interstitial lung disease in systemic sclerosis predicts long-term survival in two independent clinical trial cohorts

(2018) Elizabeth R Volkmann et al.   ANNALS OF THE RHEUMATIC DISEASES

Short-Term Pulmonary Function Trends Are Predictive of Mortality in Interstitial Lung Disease Associated With Systemic Sclerosis

(2017) Nicole S. Goh et al.   Arthritis & Rheumatology

Update of EULAR recommendations for the treatment of systemic sclerosis

(2016) Otylia Kowal-Bielecka et al.   ANNALS OF THE RHEUMATIC DISEASES

Association between inflammatory biomarkers and all-cause, cardiovascular and cancer-related mortality

(2016) Archana Singh-Manoux et al.   CANADIAN MEDICAL ASSOCIATION JOURNAL

Mycophenolate mofetil versus oral cyclophosphamide in scleroderma-related interstitial lung disease (SLS II): a randomised controlled, double-blind, parallel group trial

(2016) Donald P Tashkin et al.   Lancet Respiratory Medicine

Fitting Linear Mixed-Effects Models Usinglme4

(2015) Douglas Bates et al.   Journal of Statistical Software

Autologous Hematopoietic Stem Cell Transplantation vs Intravenous Pulse Cyclophosphamide in Diffuse Cutaneous Systemic Sclerosis

(2014) Jacob M. van Laar et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Efficacy and Safety of Nintedanib in Idiopathic Pulmonary Fibrosis

(2014) Luca Richeldi et al.   NEW ENGLAND JOURNAL OF MEDICINE

2013 Classification Criteria for Systemic Sclerosis: An American College of Rheumatology/European League Against Rheumatism Collaborative Initiative

(2013) Frank van den Hoogen et al.   ARTHRITIS AND RHEUMATISM

Does C-Reactive Protein Predict the Long-Term Progression of Interstitial Lung Disease and Survival in Patients With Early Systemic Sclerosis?

(2013) Xiaochun Liu et al.   ARTHRITIS CARE & RESEARCH

Update on the profile of the EUSTAR cohort: an analysis of the EULAR Scleroderma Trials and Research group database

(2012) Florian M P Meier et al.   ANNALS OF THE RHEUMATIC DISEASES

Prednisone, Azathioprine, andN-Acetylcysteine for Pulmonary Fibrosis

(2012)   NEW ENGLAND JOURNAL OF MEDICINE

Association of C-reactive protein with high disease activity in systemic sclerosis: Results from the Canadian Scleroderma Research Group

(2012) Chayawee Muangchan et al.   ARTHRITIS CARE & RESEARCH

Predicting treatment outcomes and responder subsets in scleroderma-related interstitial lung disease

(2011) Michael D. Roth et al.   ARTHRITIS AND RHEUMATISM

Trends in mortality in patients with systemic sclerosis over 40 years: a systematic review and meta-analysis of cohort studies

(2011) M. Elhai et al.   RHEUMATOLOGY

Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database

(2010) A. J. Tyndall et al.   ANNALS OF THE RHEUMATIC DISEASES